FDA Drug Application (022115) for LAMICTAL XR by GLAXOSMITHKLINE LLC

Back to FDA Applications sponsored by GLAXOSMITHKLINE LLC

Application Number022115
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage25MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameLAMICTAL XR
Active IngredientLAMOTRIGINE

Active IngredientCount
List of drugs with Active Ingredient LAMOTRIGINE5


Back to FDA Applications sponsored by GLAXOSMITHKLINE LLC